GlaxoSmithKline PLC at UBS Global Consumer & Retail Conference (Virtual) Transcript
Hello, everyone, and welcome to this Haleon fireside chat. My name is Guillaume Delmas. I head the European food and HPC team here at UBS. So today, absolutely delighted to have with us Haleon's Chief Financial Officer, Tobias Hestler. Tobias, thank you for your time today. Plenty to discuss. As you know, Haleon had its Capital Markets Day last week and the planned demerger should occur in July of this year.
So for the purpose of this fireside chat, I thought I would mostly focus on your medium-term prospects, both at the group level, but also for each of your 3 divisions. And then maybe spend the last 5 to 10 minutes focusing more on short-term priorities, potentially challenges.
Questions & Answers
(Operator Instructions) And with that, let's start. So Tobias, on your medium-term organic sales growth ambitions, you are targeting 4% to 6%. Your category growth, you estimate is
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
